# Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED

> **NCT06944353** · NA · NOT_YET_RECRUITING · sponsor: **Northwestern University** · enrollment: 4704 (estimated)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Steatosis of Liver
- Metabolic Dysfunction-Associated Steatotic Liver Disease

## Interventions

- **BEHAVIORAL:** STIRRED

## Key facts

- **NCT ID:** NCT06944353
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-01
- **Final completion:** 2028-07
- **Target enrollment:** 4704 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06944353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06944353, "Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06944353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*